Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Sage Biopharma · Predicate Candidate Screening

6 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

272 daysmedian FDA review time
300 days90th percentile
6clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K003734SERUM PROTEIN SUBSTITUTESage Biopharma2000-12-21170
K002836MEDIA FOR GAMETE PREPARATION AND EMBRYO CULTURESage Biopharma2000-10-03210
K991396WATER FOR TISSUE CULTURE, MODELS 500 L & 1.5 LSage Biopharma2000-02-153000
K991393HYALURONIDASE, 80 U/MLSage Biopharma2000-02-022870
K9913901.5 M PROPANEDIOL FREEZING MEDIUM, 1.5 PROPANEDIOL 0.1 SUCROSage Biopharma2000-01-182722
K991378PHOSPHATE BUFFERED SALINE (PBS), PHOSPHATE BUFFERED SALINE WSage Biopharma1999-09-241560

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams: atlasbyauro.com/fda